Sign in
Enrolling by invitationNo phase

Cholesterol Cream vs Urea Cream for Skin Barrier and Quality of Life in Ichthyosis

Key facts

Who runs it
Institute of Dermatology, Thailand
Where
Thailand1 site in 1 countryChoose a country to see its sites
Trial code
Status
Enrolling by invitation
People taking part
24 people, planned
Started
15 Jul 2026
Expected to end
30 Jun 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • 10% Cholesterol Cream
  • 10% Urea cream
Record updated
12 November 2026

Who can take part

Age
7 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Male or female patients aged 7 to 65 years
  • Confirmed diagnosis of Autosomal Recessive Congenital Ichthyosis (ARCI), established by history, family/genetic history, clinical presentation, and/or genetic testing
  • Disease activity stable (not in an acute flare)
  • Thai nationality
  • Receiving care at the Institute of Dermatology
  • Willing and able to provide informed consent (or, for participants under 18, assent with parental/legal guardian consent)

Who cannot take part

  • Presence of any other concurrent skin disease
  • Known history of allergy to any component of the study creams
  • Active skin infection (e.g., herpes zoster, viral, fungal, bacterial, or parasitic infection)
  • History of any malignancy
  • Pregnant (confirmed by positive urine pregnancy test), breastfeeding, or planning pregnancy during the study period

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 7 and 65 years old?

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study looks at whether a cream containing 10% cholesterol works better than a cream containing 10% urea for people with autosomal recessive congenital ichthyosis (ARCI), a rare inherited skin condition that causes dry, thickened, scaly skin from birth.

Read full original descriptionShow less

People with ARCI have a weakened skin barrier because their skin cannot properly produce or arrange the natural fats (lipids) needed to keep moisture in and irritants out. This leads to excessive water loss through the skin, dryness, itching, cracking, and a higher risk of skin infections. The current standard treatment is urea cream, which helps soften and remove scale but does not repair the underlying fat structure of the skin barrier. Cholesterol is one of the key natural fats that makes up a healthy skin barrier, so applying it directly to the skin may help rebuild that barrier more effectively than urea.

In this study, each participant will have one cream applied to one side of the body and the other cream applied to the matching area on the opposite side, so that each person acts as their own comparison. Researchers will measure how much water the skin loses (transepidermal water loss), skin hydration, and skin pH before and after treatment. They will also assess dryness and itching, take standardized clinical photographs, and ask participants to complete quality-of-life questionnaires (the Dermatology Life Quality Index, or its children's version, the Children's Dermatology Life Quality Index) as well as a satisfaction questionnaire for each cream.

The goal is to find out whether cholesterol cream restores the skin barrier better than urea cream, reduces dryness and itching more effectively, and leads to a better quality of life for people living with ARCI. The results may help guide more targeted skin care recommendations for this rare genetic condition.

This study is being conducted at the Institute of Dermatology, Bangkok, Thailand, and has been approved by the Institute's Ethics Committee.

The 2 groups in the trial

  • Cholesterol Cream SideTreatment being tested

    The body area randomized to receive topical 10% cholesterol cream, applied twice daily to a designated skin site for the duration of the treatment period. This arm represents one side of the within-participant, split-body comparison, in which each participant simultaneously receives 10% cholesterol cream on one body area and 10% urea cream on the contralateral, anatomically matched area. Outcomes assessed on this side include transepidermal water loss (TEWL), skin hydration, skin surface pH, clinical dryness and pruritus severity, and standardized clinical photography.

    Treatment: 10% Cholesterol Cream

  • Urea Cream SideExisting treatment, for comparison

    The contralateral, anatomically matched body area randomized to receive topical 10% urea cream, applied twice daily for the duration of the treatment period, serving as the active comparator. This arm represents the other side of the within-participant, split-body comparison, in which each participant simultaneously receives 10% urea cream on this body area and 10% cholesterol cream on the corresponding area on the opposite side. Outcomes assessed on this side include transepidermal water loss (TEWL), skin hydration, skin surface pH, clinical dryness and pruritus severity, and standardized clinical photography, allowing direct within-participant comparison against the cholesterol cream side.

    Treatment: 10% Urea cream

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Comparative Study on the Efficacy of 10% Cholesterol Cream Versus 10% Urea Cream in Improving Skin Barrier Function and Quality of Life in Patients With Autosomal Recessive Congenital Ichthyosis
Criteria questions
Built from NCT07689435, who can take part
Record updated
12 November 2026